tiprankstipranks
Trending News
More News >

New Portfolio - New Portfolio

Saulius Alisauskas

New Portfolio
Individual Investor
Ranked #500,447 out of 821,453 TipRanks' Investors
Success Rate
48%
12 out of 25
profitable transactions
Average Return
2.52%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 14.67%
6-Month Return▲ 440.86%
12-Month Return▲ 167.23%
YTD Return▲ 153.30%
Total Return▲ 175.72%

Best Trade

Opened at
Closed at-
Gain▲ 133.21%

Bio

Performance

89.12%0-89.12%
▼ 6.38%
▼ 5.57%
▼ 24.79%
Mar 2025
▲ 0.80%
▼ 0.87%
▲ 19.53%
Apr 2025
▲ 11.63%
▲ 6.28%
▼ 1.88%
May 2025
▲ 9.25%
▲ 5.14%
▲ 34.56%
Jun 2025
▲ 7.60%
▲ 2.30%
▲ 89.12%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 38.86%
Aug 2025
▲ 12.88%
▲ 3.56%
▲ 6.33%
Sep 2025
▲ 1.27%
▲ 0.45%
▲ 12.05%
Oct 2025
TipRanks AverageS&P 500Investor Portfolio
▼ 6.38%▼ 5.57%▼ 24.79%
▲ 0.80%▼ 0.87%▲ 19.53%
▲ 11.63%▲ 6.28%▼ 1.88%
▲ 9.25%▲ 5.14%▲ 34.56%
▲ 7.60%▲ 2.30%▲ 89.12%
▲ 2.76%▲ 2.05%▲ 38.86%
▲ 12.88%▲ 3.56%▲ 6.33%
▲ 1.27%▲ 0.45%▲ 12.05%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Pioneer Power Solutions
0%
▲ 24.42%
1
Open
Aug 27, 2025
Mynaric AG
▼ 97.56%
2
Close
Aug 01, 2025
UAV
0%
▼ 83.05%
1
Open
Jan 16, 2025
Syros Pharmaceuticals
0%
▼ 98.91%
1
Open
Aug 20, 2024
YieldMax COIN Option Income Strategy ETF
0%
▲ 53.35%
1
Open
Aug 07, 2024
FibroGen
0%
▼ 0.17%
1
Open
Aug 01, 2024
Nvidia
0%
▲ 48.29%
2
Sell
Jul 30, 2024
SeaStar Medical Holding
▲ 78.68%
3
Close
Jun 21, 2024
MicroCloud Hologram
▼ 0.13%
2
Close
Jun 21, 2024
Taysha Gene Therapies
7.44%
▲ 60.27%
1
Open
Jun 18, 2024
Realty Income
▼ 1.78%
2
Close
Jun 17, 2024
Ovid Therapeutics
77.31%
▲ 133.21%
1
Open
Jun 17, 2024
Jade Biosciences
0%
▲ 46.86%
1
Open
Jun 17, 2024
TSMC
▲ 2.25%
2
Close
Jun 11, 2024
Roblox
▲ 7.97%
2
Close
Jun 06, 2024
MacroGenics
15.25%
▼ 62.98%
2
Buy
Jun 05, 2024
CytomX Therapeutics
▼ 14.80%
2
Close
Jun 05, 2024
Lyra Therapeutics
▼ 10.06%
2
Close
Jun 05, 2024
Mobile-health Network Solutions Class A
▼ 15.86%
2
Close
Jun 05, 2024
Spruce Biosciences
▲ 10.96%
3
Close
May 15, 2024